Oral contraceptives and venous thromboembolism

BMJ 2009; 339 doi: http://dx.doi.org/10.1136/bmj.b3164 (Published 13 August 2009)
Cite this as: BMJ 2009;339:b3164

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Nick Dunn, senior lecturer in medical education
  1. 1Biomedical Sciences Building, University of Southampton Medical School, Southampton SO16 7PX
  1. nick.dunn{at}soton.ac.uk

    Pills containing either levonorgestrel or norethisterone with the lowest possible dose of oestrogen are advised as first choice.

    More than 100 million women use the oral contraceptive pill worldwide.1 Many types of pill are available—26 types are listed in the British National Formulary—and the choice of which one to use is important to the women who use them and their doctors. Two linked studies assess the risk of venous thromboembolism in women taking the combined oral contraceptive.2 3

    All oral contraceptives are effective in preventing pregnancy if they are taken correctly, so the choice of which one to use rests on the profile of side effects. Venous thromboembolism is one of the most serious side effects, and although it is rare, it can cause death (in about 1-2% of all cases of venous thromboembolism in women taking the pill).

    Van Hylckama Vlieg and colleagues (doi:10.1136/bmj.b2921) present a case-control study from six anticoagulation clinics in the Netherlands, and Lidegaard …

    Get access to this article and all of bmj.com for the next 14 days

    Sign up for a 14 day free trial today

    Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL